NASDAQ : CRVS
Corvus Pharmaceuticals, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 10.23 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 860.56M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 11.43M | 9.25M | 8.16M | 6.80M | 7.51M | 9.28M |
| Research & Development | 45.53M | 33.72M | 19.39M | 16.53M | 24.47M | 29.11M |
| Operating Expenses | 56.96M | 42.97M | 27.55M | 23.33M | 31.98M | 38.40M |
| Operating Income | -56.96M | -42.97M | -27.55M | -23.33M | -31.98M | -38.40M |
| Interest & Investment Income | 5.17M | 2.50M | 1.82M | 1.58M | 654.00K | |
| Earnings From Equity Investments | -2.34M | -1.96M | -3.20M | -5.28M | -10.01M | -4.83M |
| Other Non Operating Income (Expenses) | 27.14M | -33.38M | -15.00K | |||
| EBT Excluding Unusual Items | -54.13M | -15.28M | -62.30M | -27.03M | -41.33M | -43.24M |
| Gain (Loss) on Sale of Assets | 5.00K | 22.00K | ||||
| Pretax Income | -54.13M | -15.28M | -62.29M | -27.03M | -41.31M | -43.24M |
| Net Income | -54.13M | -15.28M | -62.29M | -27.03M | -41.31M | -43.24M |
| Net Income to Common | -54.13M | -15.28M | -62.29M | -27.03M | -41.31M | -43.24M |
| Shares Outstanding (Basic) | 87.08M | 78.96M | 60.99M | 48.03M | 46.55M | 41.85M |
| Shares Outstanding (Diluted) | 87.08M | 79.74M | 60.99M | 48.03M | 46.55M | 41.85M |
| EPS (Basic) | -0.62 | -0.19 | -1.02 | -0.56 | -0.89 | -1.03 |
| EPS (Diluted) | -0.62 | -0.53 | -1.02 | -0.56 | -0.89 | -1.03 |
| Free Cash Flow | -45.23M | -32.97M | -25.42M | -23.97M | -27.29M | -36.72M |
| Free Cash Flow Per Share | -0.52 | -0.41 | -0.42 | -0.50 | -0.59 | -0.88 |
| EBITDA | -56.85M | -42.87M | -27.46M | -23.18M | -31.61M | -37.94M |
| D&A For EBITDA | 117.00K | 105.00K | 85.00K | 151.00K | 367.00K | 460.00K |
| EBIT | -56.96M | -42.97M | -27.55M | -23.33M | -31.98M | -38.40M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 18.91M | 4.58M | 8.74M | 12.62M | 13.16M | 63.46M |
| Short-Term Investments | 196.32M | 52.17M | 43.22M | 14.53M | 29.14M | 5.99M |
| Cash & Short-Term Investments | 215.23M | 56.75M | 51.96M | 27.15M | 42.30M | 69.45M |
| Accounts Receivable | 6.00K | 37.00K | 75.00K | 26.00K | 588.00K | 507.00K |
| Other Receivables | 1.84M | 337.00K | 141.00K | 37.00K | 45.00K | 32.00K |
| Receivables | 1.85M | 374.00K | 216.00K | 63.00K | 633.00K | 539.00K |
| Prepaid Expenses | 394.00K | 173.00K | 470.00K | 375.00K | 434.00K | 454.00K |
| Other Current Assets | 3.49M | 917.00K | 1.76M | 369.00K | 294.00K | 868.00K |
| Total Current Assets | 220.97M | 58.21M | 54.41M | 27.96M | 43.66M | 71.31M |
| Property, Plant & Equipment | 1.49M | 1.06M | 1.33M | 1.39M | 2.57M | 3.64M |
| Long-Term Investments | 15.11M | 10.99M | 12.54M | 16.12M | 21.88M | 34.27M |
| Other Long-Term Assets | 1.71M | 855.00K | 632.00K | 89.00K | 129.00K | 236.00K |
| Total Assets | 239.27M | 71.12M | 68.91M | 45.55M | 68.24M | 109.45M |
| Accounts Payable | 4.05M | 2.49M | 2.58M | 1.52M | 1.98M | 1.56M |
| Accrued Expenses | 8.87M | 6.25M | 3.44M | 3.73M | 7.39M | 6.96M |
| Current Portion of Leases | 454.00K | 403.00K | 185.00K | 1.37M | 1.23M | 1.05M |
| Other Current Liabilities | 299.00K | 238.00K | 29.20M | 245.00K | 158.00K | 121.00K |
| Total Current Liabilities | 13.67M | 9.38M | 35.40M | 6.87M | 10.75M | 9.69M |
| Long-Term Leases | 274.00K | 534.00K | 937.00K | 1.37M | 2.60M | |
| Total Liabilities | 13.95M | 9.91M | 36.34M | 6.87M | 12.12M | 12.29M |
| Common Stock | 8.00K | 7.00K | 7.00K | 5.00K | 5.00K | 5.00K |
| Additional Paid-In Capital | 670.56M | 474.39M | 430.86M | 374.36M | 364.36M | 361.67M |
| Retained Earnings | -443.94M | -412.29M | -397.01M | -334.72M | -307.69M | -266.38M |
| Comprehensive Income & Other | -1.29M | -896.00K | -1.29M | -967.00K | -563.00K | 1.87M |
| Total Common Equity | 225.33M | 61.20M | 32.57M | 38.68M | 56.12M | 97.16M |
| Shareholders' Equity | 225.33M | 61.20M | 32.57M | 38.68M | 56.12M | 97.16M |
| Total Liabilities & Equity | 239.27M | 71.12M | 68.91M | 45.55M | 68.24M | 109.45M |
| Total Debt | 728.00K | 937.00K | 1.12M | 1.37M | 2.60M | 3.65M |
| Net Cash (Debt) | 214.50M | 55.81M | 50.84M | 25.77M | 39.70M | 65.80M |
| Net Cash Per Share | 2.46 | 0.70 | 0.83 | 0.54 | 0.85 | 1.57 |
| Filing Date Shares Outstanding | 84.12M | 83.99M | 68.14M | 49.04M | 46.57M | 46.55M |
| Total Common Shares Outstanding | 84.12M | 74.70M | 67.90M | 49.04M | 46.55M | 46.55M |
| Working Capital | 207.29M | 48.83M | 19.00M | 21.09M | 32.91M | 61.62M |
| Book Value Per Share | 2.68 | 0.82 | 0.48 | 0.79 | 1.21 | 2.09 |
| Tangible Book Value | 225.33M | 61.20M | 32.57M | 38.68M | 56.12M | 97.16M |
| Tangible Book Value Per Share | 2.68 | 0.82 | 0.48 | 0.79 | 1.21 | 2.09 |
| Machinery | 3.21M | 2.84M | 2.69M | 2.85M | 2.81M | 2.62M |
| Construction In Progress | 300.00K | |||||
| Leasehold Improvements | 33.00K | 33.00K | 2.08M | 2.08M | 2.08M | 2.08M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -54.13M | -15.28M | -62.29M | -27.03M | -41.31M | -43.24M |
| Depreciation & Amortization | 117.00K | 105.00K | 85.00K | 151.00K | 367.00K | 460.00K |
| Loss (Gain) From Sale of Assets | -5.00K | -22.00K | ||||
| Loss (Gain) From Sale of Investments | -552.00K | -1.34M | -1.14M | -894.00K | -170.00K | 239.00K |
| Loss (Gain) on Equity Investments | 2.34M | 1.96M | 3.20M | 5.28M | 10.01M | 4.83M |
| Stock-Based Compensation | 8.08M | 5.33M | 3.00M | 2.15M | 2.69M | 4.23M |
| Other Operating Activities | -27.14M | 33.38M | ||||
| Change in Accounts Receivable | 80.00K | 38.00K | -49.00K | 562.00K | -81.00K | -507.00K |
| Change in Accounts Payable | 910.00K | -91.00K | 1.06M | -451.00K | 411.00K | -1.90M |
| Change in Other Net Operating Assets | -1.38M | 3.63M | -2.65M | -3.71M | 1.08M | -827.00K |
| Operating Cash Flow | -44.53M | -32.80M | -25.42M | -23.93M | -27.02M | -36.72M |
| Capital Expenditures | -698.00K | -174.00K | -34.00K | -269.00K | -5.00K | |
| Sale of Property, Plant & Equipment | 5.00K | 22.00K | ||||
| Investment in Securities | -141.85M | -7.62M | -27.49M | 15.57M | -23.03M | 21.57M |
| Investing Cash Flow | -142.55M | -7.80M | -27.48M | 15.54M | -23.28M | 21.56M |
| Issuance of Common Stock | 191.29M | 36.43M | 35.06M | 7.86M | 62.16M | |
| Other Financing Activities | 13.96M | |||||
| Financing Cash Flow | 191.29M | 36.43M | 49.03M | 7.86M | 62.16M | |
| Net Cash Flow | 4.21M | -4.16M | -3.88M | -539.00K | -50.30M | 47.00M |
| Free Cash Flow | -45.23M | -32.97M | -25.42M | -23.97M | -27.29M | -36.72M |
| Free Cash Flow Per Share | -0.52 | -0.41 | -0.42 | -0.50 | -0.59 | -0.88 |
| Levered Free Cash Flow | -27.40M | -46.86M | 13.96M | -15.79M | -15.82M | -22.52M |
| Unlevered Free Cash Flow | -27.40M | -46.86M | 13.96M | -15.79M | -15.82M | -22.52M |
| Change in Working Capital | -385.00K | 3.58M | -1.65M | -3.59M | 1.41M | -3.24M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 815.97M | 575.05M | 343.78M | 86.31M | 39.57M | 112.18M |
| Enterprise Value | 601.47M | 510.37M | 302.48M | 55.83M | -7.18M | 39.74M |
| Last Close Price | 9.70 | 7.70 | 5.35 | 1.76 | 0.85 | 2.41 |
| PB Ratio | 3.62 | 9.39 | 10.56 | 2.23 | 0.70 | 1.16 |
| P/TBV Ratio | 3.62 | 9.39 | 10.56 | 2.23 | 0.70 | 1.16 |
| Debt / Equity Ratio | 0.00 | 0.01 | 0.03 | 0.04 | 0.05 | 0.04 |
| Net Debt / Equity Ratio | -0.95 | -0.91 | -1.56 | -0.67 | -0.71 | -0.68 |
| Net Debt / EBITDA Ratio | 3.77 | 1.30 | 1.85 | 1.11 | 1.26 | 1.74 |
| Net Debt / FCF Ratio | 4.74 | 1.69 | 2.00 | 1.07 | 1.46 | 1.79 |
| Quick Ratio | 15.88 | 6.09 | 1.47 | 3.96 | 3.99 | 7.22 |
| Current Ratio | 16.16 | 6.21 | 1.54 | 4.07 | 4.06 | 7.36 |
| Return on Equity (ROE) | -35.43% | -32.60% | -174.85% | -57.02% | -53.90% | -51.08% |
| Return on Assets (ROA) | -21.66% | -38.36% | -30.09% | -25.63% | -22.50% | -24.61% |
| Return on Capital Employed (ROCE) | -25.20% | -69.60% | -82.20% | -60.30% | -55.60% | -38.50% |
| Earnings Yield | -6.44% | -2.66% | -18.12% | -31.32% | -104.39% | -38.55% |
| FCF Yield | -5.54% | -5.73% | -7.40% | -27.77% | -68.97% | -32.73% |
| Buyback Yield / Dilution | -22.16% | -30.76% | -26.99% | -3.16% | -11.23% | -41.98% |